Latest News

This week at Yale School of Medicine (YSM): Researchers aim toward treatments for Parkinson's disease, evaluate wearable sensors for assessing knee osteoarthritis, and develop recommendations for when to evaluate patients for axial spondyloarthritis.

AI tools like ChatGPT can act increasingly as capable research partners, but generating original scientific hypotheses on their own is still challenging.

The PRISMS study will investigate an anti-inflammatory drug in individuals with REM sleep behavior disorder.

Macrophages maintain the function of certain organs by eliminating waste products. Studying this process could lead to clues for healthier aging.

Liza Konnikova, MD, PhD (left), and Sarah N. Taylor, MD, recently received a research award from the Binational Science Foundation for a study looking at the influence of diet on the intestinal health and growth of preterm infants.

Anh Phu, a member of the Dixit Laboratory at Yale School of Medicine, was recently named recipient of a National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Award F30 Predoctoral Fellowship.

A new experimental vaccine is showing incredible potential as a treatment option for melanoma, one of the most dangerous types of skin cancer. Compared to other types of skin cancer, melanoma is much more likely to spread to other parts of the body if not found and treated early. Even when it is surgically removed, melanoma can return, or recur.

Adults at high risk of melanoma recurrence and spread were able to stay cancer-free with personalized vaccines made with mRNA technology.